These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 2450185)
1. Receptor subtypes involved in the action of calcium antagonists. van Zwieten PA; Timmermans PB; van Heiningen PN J Hypertens Suppl; 1987 Dec; 5(4):S21-8. PubMed ID: 2450185 [TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of calcium antagonist drugs on vasoconstriction induced by vascular alpha 2-adrenoceptor stimulation. van Zwieten PA; Timmermans PB; Thoolen MJ; Wilffert B; De Jonge A Am J Cardiol; 1986 Feb; 57(7):11D-15D. PubMed ID: 2869674 [TBL] [Abstract][Full Text] [Related]
3. Receptor subtypes involved in the action of calcium entry blockers. van Zwieten PA; Timmermans PB Ann N Y Acad Sci; 1988; 522():351-60. PubMed ID: 2454059 [TBL] [Abstract][Full Text] [Related]
13. Specific alpha-adrenoceptor-mediated vasoconstriction in human veins and interaction with the calcium entry blockers nifedipine and diltiazem. Schulte KL; Laber E; Meyer-Sabellek WA; Distler A; Gotzen R J Hypertens Suppl; 1985 Dec; 3(3):S239-41. PubMed ID: 2856818 [TBL] [Abstract][Full Text] [Related]
15. Vascular effects of calcium antagonists: implications for hypertension and other risk factors for coronary heart disease. van Zwieten PA Am J Cardiol; 1989 Nov; 64(17):117I-121I. PubMed ID: 2554709 [TBL] [Abstract][Full Text] [Related]
16. ANG II- and TxA(2)-induced mesenteric vasoconstriction in rats is mediated by separate cell signaling pathways. Bauer J; Dau C; Cavarape A; Schaefer F; Ehmke H; Parekh N Am J Physiol; 1999 Jul; 277(1):H1-7. PubMed ID: 10409174 [TBL] [Abstract][Full Text] [Related]
17. Hypotensive activity of calcium entry blockers in rats. Relationship with depression of alpha 2-adrenoceptor-mediated vasopressor responses. Van Meel JC; Timmermans PB; Van Zwieten PA Eur J Pharmacol; 1983 Aug; 92(1-2):27-34. PubMed ID: 6313390 [TBL] [Abstract][Full Text] [Related]
18. Central and peripheral alpha-adrenoceptors. van Zwieten PA; van Meel JC; de Jonge A; Wilffert B; Timmermans PB J Cardiovasc Pharmacol; 1982; 4 Suppl 1():S19-24. PubMed ID: 6175838 [TBL] [Abstract][Full Text] [Related]
19. Studies on the mechanism of arterial vasodilation produced by the novel antihypertensive agent, carvedilol. Nichols AJ; Gellai M; Ruffolo RR Fundam Clin Pharmacol; 1991; 5(1):25-38. PubMed ID: 1712335 [TBL] [Abstract][Full Text] [Related]
20. Calcium and chloride channel activation by angiotensin II-AT1 receptors in preglomerular vascular smooth muscle cells. Fuller AJ; Hauschild BC; Gonzalez-Villalobos R; Awayda MS; Imig JD; Inscho EW; Navar LG Am J Physiol Renal Physiol; 2005 Oct; 289(4):F760-7. PubMed ID: 15942047 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]